GILD

Q: What is the price of Gilead Sciences (GILD) today?

The current price of Gilead Sciences (GILD) is $ 134.43, representing a 26.11% gain over the past year. The stock began the year trading around $ 122.74 and is currently priced at $ 134.43. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Gilead Sciences (GILD) pay dividends?

In the last year, Gilead Sciences (GILD) distributed dividends in the month of March, totaling $ 0.82. The Dividend Yield for the last 12 months is 2.37%.

Gilead Sciences Inc.

Price

$ 134.43

return (12m)

26.11%

p/e

18.12

p/bv

7.13

DIVIDEND YIELD

2.37%

GILD price

Gilead Sciences

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment GILD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

2.74%

3 months

-9.34%

1 year

26.11%

2 years

124.16%

5 years

146.85%

10 years

123.56%

Fundamentals GILD

review the fundamentals of Gilead Sciences shares

P/E

18.12

Sector: -3.99 Industry: -3.99

P/S (PSR)

5.62

Sector: -4.17 Industry: -4.17

P/BV

7.13

Sector: 2.00 Industry: 2.00

DIVIDEND YIELD (DY)

2.37%

Sector: - Industry: -

ROA

16.38%

Sector: -65.15% Industry: -65.15%

ROE

39.33%

Sector: -65.39% Industry: -65.39%

ROIC

18.49%

Sector: -2,913.92% Industry: -2,913.92%

NET MARGIN

30.99%

Sector: -40.35% Industry: -40.35%

GROSS MARGIN

79.35%

Sector: 36.51% Industry: 36.51%

OPERATING MARGIN

40.02%

Sector: -39.30% Industry: -39.30%

EV/EBITDA

11.53

Sector: -4.10 Industry: -4.10

EV/EBIT

14.23

Sector: -4.18 Industry: -4.18

PRICE-TO-ASSETS

2.97

Sector: 1.47 Industry: 1.47

BVPS

18.87

Sector: 1.88 Industry: 1.88

EPS

7.42

Sector: -2.14 Industry: -2.14

EQUITY-TO-ASSETS RATIO

0.42

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.58

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

1.72%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

8.16%

Sector: - Industry: -

FAIR VALUE OF Gilead Sciences ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current Price

$ 134.43

Fair Value

$ 56.13

Upside Return potential.

-58.25%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals GILD

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	25.65	6.65	25.92%	2.32%	$ 539.72 B	21.83%
PFE	19.57	1.62	8.29%	6.68%	$ 146.58 B	11.83%
ABBV	106.01	-58.28	-54.98%	3.10%	$ 385.36 B	5.79%
NVO	10.68	6.45	60.40%	4.09%	$ 202.51 B	37.15%
MRK	32.85	6.39	19.45%	2.80%	$ 293.48 B	13.59%
AZN	27.68	6.07	21.93%	1.72%	$ 287.60 B	17.19%
BMY	16.02	5.80	36.19%	4.37%	$ 116.53 B	15.01%
ZTS	12.27	10.03	81.75%	2.64%	$ 32.42 B	27.79%
REGN	14.45	2.03	14.08%	0.58%	$ 63.94 B	29.65%
HALO	22.51	35.75	158.82%	0.00%	$ 7.85 B	23.13%
AMGN	23.32	19.79	84.87%	2.87%	$ 181.87 B	20.96%
MCK	19.02	-108.61	-570.98%	0.43%	$ 90.58 B	1.18%
HRMY	12.58	2.01	16.00%	0.00%	$ 1.83 B	16.20%
VRTX	26.20	5.87	22.41%	0.00%	$ 113.68 B	35.51%
CAH	29.74	-17.31	-58.20%	1.04%	$ 46.25 B	0.62%
ADMA	11.39	4.82	42.37%	0.00%	$ 1.88 B	32.43%
BIIB	21.00	1.54	7.36%	0.00%	$ 28.81 B	13.81%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

GILD Historical Dividends

current DY: 2.37%

5-year average DY: 3.67%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	06/12/2026	06/29/2026	0,82000000
Dividends	03/12/2026	03/30/2026	0,82000000
Dividends	12/12/2025	12/30/2025	0,79000000
Dividends	09/12/2025	09/29/2025	0,79000000
Dividends	06/12/2025	06/27/2025	0,79000000
Dividends	03/13/2025	03/28/2025	0,79000000
Dividends	12/12/2024	12/30/2024	0,77000000
Dividends	09/12/2024	09/27/2024	0,77000000
Dividends	06/13/2024	06/27/2024	0,77000000
Dividends	03/13/2024	03/28/2024	0,77000000
Dividends	12/13/2023	12/28/2023	0,75000000
Dividends	09/13/2023	09/28/2023	0,75000000
Dividends	06/13/2023	06/29/2023	0,75000000
Dividends	03/13/2023	03/30/2023	0,75000000
Dividends	12/13/2022	12/29/2022	0,73000000
Dividends	09/13/2022	09/29/2022	0,73000000
Dividends	06/13/2022	06/29/2022	0,73000000
Dividends	03/11/2022	03/30/2022	0,73000000
Dividends	12/13/2021	12/30/2021	0,71000000
Dividends	09/13/2021	09/29/2021	0,71000000
Dividends	06/11/2021	06/29/2021	0,71000000
Dividends	03/11/2021	03/30/2021	0,71000000
Dividends	12/11/2020	12/30/2020	0,68000000
Dividends	09/11/2020	09/29/2020	0,68000000
Dividends	06/10/2020	06/29/2020	0,68000000
Dividends	03/11/2020	03/30/2020	0,68000000
Dividends	12/11/2019	12/30/2019	0,63000000
Dividends	09/11/2019	09/27/2019	0,63000000
Dividends	06/12/2019	06/27/2019	0,63000000
Dividends	03/13/2019	03/28/2019	0,63000000
Dividends	12/12/2018	12/28/2018	0,57000000
Dividends	09/12/2018	09/27/2018	0,57000000
Dividends	06/13/2018	06/28/2018	0,57000000
Dividends	03/14/2018	03/29/2018	0,57000000
Dividends	12/13/2017	12/28/2017	0,52000000
Dividends	09/13/2017	09/28/2017	0,52000000
Dividends	06/14/2017	06/29/2017	0,52000000
Dividends	03/14/2017	03/30/2017	0,52000000
Dividends	12/13/2016	12/29/2016	0,47000000
Dividends	09/14/2016	09/29/2016	0,47000000
Dividends	06/14/2016	06/29/2016	0,47000000
Dividends	03/14/2016	03/30/2016	0,43000000
Dividends	12/14/2015	12/30/2015	0,43000000
Dividends	09/14/2015	09/29/2015	0,43000000
Dividends	06/12/2015	06/29/2015	0,43000000

ABOUT Gilead Sciences

Gilead Sciences Inc.

Average Investor10 user rating

4.0 (86 people)

United States

39 years

Founded: 1987

1992

Time since IPO - 34 years

13.600

Employees

Gilead Sciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $166.96 Billions, with shareholders equity totaling $23.43 Billions.

The company employs approximately 13.600 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Gilead Sciences Inc. reported $29.73 Billions in revenue, generating net income of $9.22 Billions.

Key financial metrics include a P/E ratio of 18.12, a price-to-book (P/B) ratio of 7.13, and a trailing twelve-month dividend yield of 2.37%.

The company trades under the ticker GILD.

Market cap

$ 166.96 Billions

Net worth

$ 23.43 Billions

$ 23,431,000,000.00

Assets

$ 56.28 Billions

$ 56,278,000,000.00

Total Shares Outstanding

1.24 Billion

1,242,000,000

Average Daily Trading Volume

$ 6.22 Millions

$ 6,220,578.00

Sector

Health Care

Industry

Biotechnology

GILD

revenue by Business Segment Gilead Sciences

Revenue by Region Gilead Sciences

GILD revenue and profits

Financial Results GILD

DRAG THE FRAME TO SEE MORE DATA

GILD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 742.44 3,71% (12M)

P/E

19.02

0.43%

ROE

-570.98%

P/BV

-108.61

CAH - Cardinal Health

$ 196.80 29,22% (12M)

P/E

29.74

1.04%

ROE

-58.20%

P/BV

-17.31

JNJ - Johnson & Johnson

$ 225.33 50,10% (12M)

P/E

25.65

2.32%

ROE

25.92%

P/BV

6.65

MRK - Merck & Co.

$ 118.72 61,24% (12M)

P/E

32.85

2.80%

ROE

19.45%

P/BV

6.39

AZN - AstraZeneca

$ 185.67 31,33% (12M)

P/E

27.68

1.72%

ROE

21.93%

P/BV

6.07

ABBV - AbbVie

$ 217.72 20,70% (12M)

P/E

106.01

3.10%

ROE

-54.98%

P/BV

-58.28

NVO - Novo Nordisk

$ 45.58 --33,17% (12M)

P/E

10.68

4.09%

ROE

60.40%

P/BV

6.45

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 742.44 3,71% (12 M)

P/L

19.02

0.43%

ROE

-570.98%

P/VP

-108.61

CAH - Cardinal Health

$ 196.80 29,22% (12 M)

P/L

29.74

1.04%

ROE

-58.20%

P/VP

-17.31

JNJ - Johnson & Johnson

$ 225.33 50,10% (12 M)

P/L

25.65

2.32%

ROE

25.92%

P/VP

6.65

MRK - Merck & Co.

$ 118.72 61,24% (12 M)

P/L

32.85

2.80%

ROE

19.45%

P/VP

6.39

AZN - AstraZeneca

$ 185.67 31,33% (12 M)

P/L

27.68

1.72%

ROE

21.93%

P/VP

6.07

ABBV - AbbVie

$ 217.72 20,70% (12 M)

P/L

106.01

3.10%

ROE

-54.98%

P/VP

-58.28

NVO - Novo Nordisk

$ 45.58 --33,17% (12 M)

P/L

10.68

4.09%

ROE

60.40%

P/VP

6.45

Frequently Asked Questions

What is the price of Gilead Sciences (GILD) today?

The current price of Gilead Sciences (GILD) is $ 134.43, representing a 26.11% gain over the past year. The stock began the year trading around $ 122.74 and is currently priced at $ 134.43. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Gilead Sciences (GILD) pay dividends?

In the last year, Gilead Sciences (GILD) distributed dividends in the month of March, totaling $ 0.82. The Dividend Yield for the last 12 months is 2.37%.

Is Gilead Sciences (GILD) a good investment?

Gilead Sciences (GILD) is currently trading at $ 134.43 with a P/E ratio of 18.12. This represents a 6,061% premium compared to its historical average P/E. Over the past year, the stock has gained 26.11 and paid $ 0.82 in dividends, resulting in a dividend yield of 2.37%. The total shareholder return over the same period was 26.11%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Gilead Sciences (GILD) stock?

You can buy Gilead Sciences (GILD) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol GILD and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Gilead Sciences (GILD) yield today?

Over the past month, Gilead Sciences (GILD) has returned 2.74% — 26.11% over the past year, and 146.85% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 3.19 per share in dividends, resulting in a dividend yield of 2.37%.

If you were to purchase 100 shares of Gilead Sciences (GILD) today at the current price of $ 134.43 your total investment would be $ 13,443.00.

Based on historical performance, the investment would have grown to approximately:

$ 16,952.97 after 1 year
$ 33,184.05 after 5 years
$ 30,053.17 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

GILD

Gilead Sciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment GILD

review the fundamentals of Gilead Sciences shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

current DY: 2.37%

5-year average DY: 3.67%

type

Ex - Dividend Date

payment date

value

ABOUT Gilead Sciences

Gilead Sciences Inc.

United States

39 years

1992

13.600

PROFIT X PRICE GILD

Financial Results GILD

GILD cash flow

Asset, Revenue and Profit Growth - GILD

GILD balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions